FTO and Miyoshi myopathy: Moreover, cytotoxicity was significantly enhanced when the FTO inhibitor was administered together with BTZ, so the combination of a proteasome inhibitor and drug interfering with the epigenetic mechanism exerted synergistic anti-MM effects [63].